e-learning
resources
London 2016
Tuesday, 06.09.2016
Functional assessment of the airways
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung clearance index in alpha-1-antitrypsin deficiency - A follow up
Susanne Fuchs (Wesel, Germany), Susanne Fuchs, Matthias Griese, Doris Staab, Klaus Pittschieler, Frank Ahrens, Ernst Rietschel, Nicolaus Schwerk, Wolfgang Gleiber, Winfried Baden, Thomas Köhnlein, Robert Bals, Monika Gappa
Source:
International Congress 2016 – Functional assessment of the airways
Session:
Functional assessment of the airways
Session type:
Thematic Poster
Number:
4130
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Susanne Fuchs (Wesel, Germany), Susanne Fuchs, Matthias Griese, Doris Staab, Klaus Pittschieler, Frank Ahrens, Ernst Rietschel, Nicolaus Schwerk, Wolfgang Gleiber, Winfried Baden, Thomas Köhnlein, Robert Bals, Monika Gappa. Lung clearance index in alpha-1-antitrypsin deficiency - A follow up. Eur Respir J 2016; 48: Suppl. 60, 4130
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Lung clearance index is increased in patients with COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Lung clearance index in asthmatic patients
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016
Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
Lung function decline in patients with severe alpha
1
-antitrypsin deficiency
Source: International Congress 2014 – Respiratory function: quality and new technologies
Year: 2014
Lung clearance index in pediatric patients with asthma
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013
The relationship of small airways disease to spirometry and emphysema in alpha-1 antitrypsin deficiency
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Genetic influences on lung function decline in AATD
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015
Lung function in never smoking patients with alpha1antitrypsin deficiency
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
Correlation among functional respiratory parameters and disease control in asthma
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Body-plethysmographic measurements of bronchodilator response in stable COPD
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014
Correlation of nutritional status using subjective global assessment (SGA) on pulmonary function parameters in patients with COPD at the Philippine Heart Center
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013
Usefulness of respiratory impedance by measuring at functional residual capacity position
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
Emphysema distribution determines distinct pulmonary function features
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Elastance bronchodilator response reflects asthma pathology
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
Computer bronchophonography is a new lung function diagnostic method in children
Source: International Congress 2014 – Respiratory function: quality and new technologies
Year: 2014
Lung function impairment in adult asthma increases the risk of systemic inflammation
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
COPD severity related to extended measurements of lung volume, diffusion, and resistance
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Measurement of lung function deterioration in COPD by V/P SPECT
Source: International Congress 2016 – Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception
Year: 2016
Ability of lung clearance index to track changes in a routine clinical CF setting
Source: International Congress 2015 – Paediatric respiratory physiology
Year: 2015
Severity classification of DSP in COPD
Source: Annual Congress 2013 –Airway calibre, airway challenge and assessment of oxygenation
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept